Use Flamel Technologies SA media headlines concurrently with your other holdings to enhance returns of your portfolios and to back test it against optimization strategy that fits your risk preferences.
FLAMEL TECHNOLOGIES S.A. (ADR) : May 07, 2012 Flamel Technologies Announces ...
4-traders - May 7, 2012
LYON, France - May 7, 2012 - Flamel Technologies (NASDAQ: FLML) today announced its financial results for the first quarter of 2012.
Flamel Technologies Announces First Quarter 2012 Results - EON: Enhanced Online News (press release)
Flamel Technologies (FLML) Lower Following Wider than Expected Q1 Miss - StreetInsider.com (subscription)
MarketWatch (press release) - May 7, 2012
LYON, France, May 07, 2012 (BUSINESS WIRE) -- Flamel Technologies (NASDAQ:FLML) today announced its financial results for the first quarter of 2012.
Flamel Technologies (FLML) Lower Following Wider than Expected Q1 Miss - StreetInsider.com (subscription)
Flamel Technologies Announces Projected Release Date of First Quarter 2012 ...
EON: Enhanced Online News (press release) - May 1, 2012
LYON, France--(EON: Enhanced Online News)--Flamel Technologies (NASDAQ: FLML) expects to release its financial results for the first quarter of 2012, on Monday, May 7th, before the market open.
FLAMEL TECHNOLOGIES S.A. (ADR) : Flamel Technologies Announces Projected ...
4-traders - Apr 30, 2012
Flamel Technologies (NASDAQ: FLML) expects to release its financial results for the first quarter of 2012, on Monday, May 7th, before the market open.
Flamel Technologies Announces Projected Release Date of First Quarter 2012 ... - EON: Enhanced Online News (press release)
Hogan Lovells | Hogan Lovells Advises Flamel Technologies on Acquisition of ...
Linex Legal (press release) (registration) - Apr 3, 2012
WASHINGTON, DC, 3 April 2012 - Hogan Lovells announced today that it advised Lyons, France-based drug delivery technology company Flamel Technologies (NASDAQ: FLML) on its acquisition of ?clat Pharmaceuticals, a specialty pharmaceutical company based ...
The Pharma Letter - Mar 19, 2012
Lyon, France-based drug delivery firm Flamel Technologies (Nasdaq: FLML) said last week that it has acquired Eclat Pharmaceuticals, a US specialty pharmaceutical company that is focused on the development, approval, and commercialization of niche ...
Galaxy Stocks - Mar 16, 2012
Flamel Technologies SA (ADR) (NASDAQ:FLML), France-based biopharmaceutical corporation, announced that it has decided to purchase Missouri-based ?clat Pharmaceuticals that produces niche brands and generic products.
Active Stocks in News at Healthcare- NASDAQ:FLML, NASDAQ:ECYT - eStocksDaily
FDA Approves First Generic To Treat Depression; Endocyte to Submit EU ...
BioMedReports (subscription) - 10 hours ago
By Staff and Wire Reports Below is a look at some of the headlines for companies that made news in the healthcare sector on March 14, 2012.
LYON, France, Mar 14, 2012 (BUSINESS WIRE) -- Flamel Technologies (NASDAQ:FLML) today announced its financial results for the fourth quarter and year ended December 31, 2011.
Financial News Network Online - Jan 25, 2012
Flamel Technologies (NASDAQ:FLML) is a company whose shares are active, trading 2.8% higher to $5.47. The Dow Jones Industrial Average is now trading fractionally lower to 12672 and the S&P is trading fractionally higher to 1315.
Flamel Technologies SA is rated below average in revenue category among related companies. Market size based on revenue of Drug Delivery industry is currently estimated at about 8.77 Billion. Flamel adds roughly 33.17 Million in revenue claiming only tiny portion of equities under Drug Delivery industry.
Flamel Research Report
Flamel Total Debt
Based on latest financial disclosure Flamel Technologies SA has Total Debt of 18.39 M. This is 98.54% lower than that of Healthcare sector, and 98.57% lower than that of Drug Delivery industry, The Total Debt for all stocks is 99.61% higher than the company.
In most industries, total debt may also include current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meaningful to compare total debt amounts between companies that operate within the same sector.
USA 
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Summary
Fundamentals
Technicals
Performance
Valuation
Volatility
History
News
Management
Discussion
